ORYZON to provide corporate progress updates at several events in november 06/11/2023 Corporate Oryzon’s CEO, Dr. Carlos Buesa, will attend the LSX Investival Showcase, to be held on November 13 at at Old... Partners - Oryzon Genomics
ORYZON reports financial results and corporate updates for quarter ended September 30, 202... 30/10/2023 Healthcare Access to innovation Financing Corporate Research and development (R&D) expenses of $3.8 and $12.2 million for the quarter and nine months ended September 30... Partners - Oryzon Genomics
ORYZON to provide corporate progress updates at several events in October 02/10/2023 Corporate Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in... Partners - Oryzon Genomics
HOFFMANN EITLE Madrid & Barcelona celebrate their 10th anniversary in BIOSPAIN 02/10/2023 Corporate As part of BIOSPAIN, from 26 to 28 September in Barcelona, HOFFMANN EITLE Madrid & Barcelona celebrated its tenth... Partners - Hoffmann · Eitle
Oryzon announces completed patient recruitment in the PORTICO Phase IIb trial of vafidemst... 26/07/2023 Corporate Multiple primary endpoints include reduction in agitation and aggression and overall disease improvement. Recent... Partners - Oryzon Genomics
ORYZON reports financial results and corporate updates for half-year ending June 30, 2023 25/07/2023 Corporate Partners - Oryzon Genomics
Orikine Bio closes €5.5m Series Seed Financing with Sabadell Asabys and AdBio 18/07/2023 Financing Corporate New synthetic biology spin-off from the Centre for Genomic Regulation (CRG) in Barcelona developing a novel proprietary... Partners - Asabys Partners
#NewAllyAseBio | "AseBio have the same goal as us of protecting people and sustainability" 12/07/2023 Healthcare Corporate Meet Globalfinanz, our new ally. We talked to Begoña Torregrosa, partner and head of Collectives. AseBio
ORYZON Announces Voting Results from its 2023 Annual General Meeting of Shareholders 27/06/2023 Corporate All resolutions were approved and 35% of the issued shares represented. Partners - Oryzon Genomics
GENESIS Biomed opens a new office in Valencia 22/06/2023 Corporate This new location of GENESIS Biomed in the BioHub joins the existing locations in Barcelona and Madrid. Partners - GENESIS Biomed
